South Africa
South Africa has the largest HIV patient cohort in the world and is helping to lead the way in gaining access to new treatments for multidrug-resistant tuberculosis (MDR-TB).
In KwaZulu-Natal province, our project’s community-oriented approach is to increase integrated HIV testing and TB screening, as well as access and adherence to HIV treatment.
The Khayelitsha project near Cape Town continues to develop and implement treatment regimens for MDR-TB and innovative models of care for patients living with HIV and TB.
Our teams are currently responding to the coronavirus COVID-19 pandemic in South Africa.
18,600
18,6
1,390
1,39
630
63
Tuberculosis
Sustainable solutions for children and adolescents at risk of drug-resistant tuberculosis
Project Update
30 Mar 2021
Coronavirus COVID-19 pandemic
Southern Africa needs the right COVID-19 vaccines, at the right price – right now
Press Release
18 Feb 2021
Coronavirus COVID-19 pandemic
MSF supports India and South Africa ask to waive COVID-19 patent rights
Press Release
7 Oct 2020
Coronavirus COVID-19 pandemic
COVID-19 and rural South Africa
org.za
21 Sep 2020
South Africa
Western Cape begins to breathe after COVID-19 peak
Project Update
6 Aug 2020
South Africa
MSF opens field hospital as South Africa braces for COVID-19
Project Update
12 Jun 2020
HIV/AIDS
AIDS death toll stagnating due to lack of testing at community level
Press Release
1 Dec 2019
HIV/AIDS
MSF report "No time to lose" examines the fight against AIDS in 15 countries
Report
27 Nov 2019
Tuberculosis
TB drug delamanid must be more affordable and made available in more countries
Statement
10 Oct 2019
1999
1999
Contact us
MSF South Africa
7th Floor, Zurich House
70 Fox Street, Marshalltown
Johannesburg
South Africa